GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » RaySearch Laboratories AB (OTCPK:RSLBF) » Definitions » Price-to-Operating-Cash-Flow

RaySearch Laboratories AB (RaySearch Laboratories AB) Price-to-Operating-Cash-Flow : 6.63 (As of May. 06, 2024)


View and export this data going back to 2011. Start your Free Trial

What is RaySearch Laboratories AB Price-to-Operating-Cash-Flow?

As of today (2024-05-06), RaySearch Laboratories AB's share price is $8.33. RaySearch Laboratories AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.26. Hence, RaySearch Laboratories AB's Price-to-Operating-Cash-Flow Ratio for today is 6.63.

The historical rank and industry rank for RaySearch Laboratories AB's Price-to-Operating-Cash-Flow or its related term are showing as below:

RSLBF' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.45   Med: 19.63   Max: 79.27
Current: 8.86

During the past 13 years, RaySearch Laboratories AB's highest Price-to-Operating-Cash-Flow Ratio was 79.27. The lowest was 5.45. And the median was 19.63.

RSLBF's Price-to-Operating-Cash-Flow is ranked better than
66.89% of 456 companies
in the Healthcare Providers & Services industry
Industry Median: 13.05 vs RSLBF: 8.86

RaySearch Laboratories AB's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $0.33. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.26.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of RaySearch Laboratories AB was 42.20% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 11.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 13.30% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 26.50% per year.

During the past 13 years, RaySearch Laboratories AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 56.50% per year. The lowest was -20.50% per year. And the median was 17.50% per year.


RaySearch Laboratories AB Price-to-Operating-Cash-Flow Historical Data

The historical data trend for RaySearch Laboratories AB's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RaySearch Laboratories AB Price-to-Operating-Cash-Flow Chart

RaySearch Laboratories AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.48 8.55 8.13 7.27 6.79

RaySearch Laboratories AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.27 7.39 6.29 6.20 6.79

Competitive Comparison of RaySearch Laboratories AB's Price-to-Operating-Cash-Flow

For the Health Information Services subindustry, RaySearch Laboratories AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RaySearch Laboratories AB's Price-to-Operating-Cash-Flow Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where RaySearch Laboratories AB's Price-to-Operating-Cash-Flow falls into.



RaySearch Laboratories AB Price-to-Operating-Cash-Flow Calculation

RaySearch Laboratories AB's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=8.33/1.257
=6.63

RaySearch Laboratories AB's Share Price of today is $8.33.
RaySearch Laboratories AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.26.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

RaySearch Laboratories AB Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of RaySearch Laboratories AB's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


RaySearch Laboratories AB (RaySearch Laboratories AB) Business Description

Traded in Other Exchanges
Address
Sveavagen 44, P.O. Box 3297, Stockholm, SWE, 103 65
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops advanced software solutions for improved cancer treatment. The company develops and markets the RayStation* treatment planning system and RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of Sweden, North America, Asia, Europe and the rest of the world. The company generates majority of its sales from the North America.

RaySearch Laboratories AB (RaySearch Laboratories AB) Headlines